Catalyst Brief

← Calendar

Readoutin 45d

ModernaTX, Inc. — mRNA-1018-H5

Phase 3 primary completion: A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults.

Date
Jan 2027
Type
Readout
Indication
Influenza

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.